Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an International Osteoporosis Foundation (IOF) position statement
Recommendations
As issued by the authors
Risk-adapted treatment strategy
Bisphosphonates as the preferred treatment option
Original publication
Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an IOF position statement. Osteoporos Int. Published 8 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →